Middle East & Africa In Vitro Diagnostics Market USD 4.42 billion by 2031
The report "Middle East & Africa In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Infectious Disease) - Forecast to 2031" is valued at an estimated USD 3.49 billion in 2026 and is projected to reach USD 4.42 billion by 2031, at a CAGR of 4.8% during the forecast period.
Browse 120 market data Tables and 44 Figures spread through 200 Pages and in-depth TOC on "Middle East & Africa In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Infectious Disease) - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/middle-east-and-africalatin-america-in-vitro-diagnostics-market-122524661.html
The Middle East & Africa IVD market is supported by various key drivers that continue to shape demand across the region. The rising prevalence of infectious & chronic diseases has increased the need for routine & confirmatory diagnostic testing in clinical settings. Furthermore, population growth and the gradual expansion of healthcare coverage are leading to higher patient inflow across hospitals and labs. Additionally, increased emphasis on early diagnosis & disease monitoring, along with ongoing upgrades to laboratory infrastructure and diagnostic capacity, is further contributing to sustained demand for IVD testing across the Middle East & Africa.
The reagents & kits segment accounted for the largest share of the market in 2025, by product & service.
By product & service, the market includes instruments, reagents & kits, and data management software & services. Reagents & kits accounted for the largest share in 2025, driven by their continuous use across routine and specialized diagnostic tests. Each test requires consumables, resulting in recurring demand from labs and hospitals. Higher testing volumes across multiple diagnostic areas further support their dominance. The ongoing expansion of diagnostic services also continues to strengthen their contribution to overall revenues.
The point-of-care tests segment is projected to witness the highest CAGR during the forecast period.
By site of testing, the market encompasses both laboratory tests and point-of-care tests. The POC tests segment is expected to register the highest CAGR during the forecast period, owing to the need for faster and closer-to-patient testing capabilities. This demand is fueling the adoption of POC tests in emergency departments, outpatient clinics, and decentralized care settings, where immediate clinical decisions are made. Additionally, increased access to portable and user-friendly diagnostic systems is further supporting the adoption of POC tests.
The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (US), Danaher (US), Thermo Fisher Scientific Inc. (US), Siemens Healthineers AG (Germany), Sysmex Corporation (Japan), Becton, Dickinson and Company (US), bioMérieux (France), Bio-Rad Laboratories, Inc. (US), and QuidelOrtho Corporation (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Middle East & Africa In Vitro Diagnostics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
